Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs STZ✓SelectedUSD · STZGSK vs STZ performance historyLatest closeAs of-0.13%11/20
Stock and ETF performance explorer

GSK vs STZ

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+97.1%
STZ return
+8.1%
Excess return
+89.0%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioSTZExcessAlpha
1D-0.1%+0.3%-0.4%-0.2%
7D-5.3%-2.6%-2.8%-4.8%
30D-3.7%+8.3%-12.0%-5.3%
3M-7.3%+6.6%-13.9%-8.6%
6M-4.2%-4.7%+0.4%-3.6%
YTD+0.9%+5.9%-5.0%-1.1%
1Y+7.3%+11.9%-4.7%+3.9%
3Y+52.7%-35.8%+88.5%+64.7%
5Y+40.1%-33.5%+73.7%+48.6%
All+97.1%+8.1%+89.0%+83.7%

Cumulative growth

Daily Returns

Daily percentage return beside STZ.

Daily Out/Under-Performance

Portfolio return minus STZ return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × STZ return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded STZ wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling